The effect of corticosteroids and other antineoplastic agents on the generation of leukocyte migration inhibition factor.
We have shown that hydrocortisone in physiological concentrations can inhibit the production of leukocyte migration inhibition factor (LMIF), but does not diminish the action of this lymphokine. Other agents tested failed to influence LMIF production. Inhibition of LMIF production by corticosteroids was influenced by the nature of the stimulus used for the production as an effect could be seen with PHA or Con A, but not Staphylococcal enterotoxin A (SEA). Production of LMIF was promptly restored after removal of the steroids. Furthermore, addition of a calcium ionophore to PHA restored the production of LMIF even in the presence of corticosteroids. In contrast, addition of exogenous IL-2 did not correct the defect in lymphokine secretion. We believe that inhibition of the production of LMIF by steroid may lead to defective granulocytic function and thus, predispose to infection.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D000001:Calcimycin / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D007961:Leukocyte Migration-Inhibitory Factors / Q000096:biosynthesis* / Q000276:immunology; D008222:Lymphokines / Q000096:biosynthesis*; D008775:Methylprednisolone / Q000494:pharmacology; D008934:Mitogens / Q000494:pharmacology; D009000:Monocytes / Q000276:immunology
D000970:Antineoplastic Agents; D005938:Glucocorticoids; D007961:Leukocyte Migration-Inhibitory Factors; D008222:Lymphokines; D008934:Mitogens; D000001:Calcimycin; D006854:Hydrocortisone; D008775:Methylprednisolone